Concert Pharmaceuticals Announces Initiation of CTP-730 Phase 1 Clinical Trial Under Celgene Collaboration LEXINGTON, Mass.–(Sep 17, 2014)– Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has initiated a Phase 1 clinical trial of...
Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results – FREEDOM-1 study showed that ITCA 650 demonstrated positive results when added to standard oral diabetes medications. All...
Chimerix Announces Emergency Investigational New Drug Applications for Brincidofovir Authorized by FDA for Patients With Ebola Virus Disease DURHAM, N.C., Oct. 6, 2014 (GLOBE NEWSWIRE) — Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel,...
Actavis to Acquire Durata Therapeutics, Inc. – Lead Product DALVANCE™ a Novel Antibiotic for Unmet Medical Need in Hospital and Outpatient Settings – Enhances Actavis’ Long-term Growth Profile 2015+ – Experienced Development and Commercial Team...
Solaris Hospice Replaces Unsecure Email and Voicemail with TigerText Secure Messaging SANTA MONICA, CA (October 7, 2014) – TigerText, the leader in secure, real-time messaging for the enterprise, today announced that Solaris Hospice, a hospice care organization...
Kit Check Announces RFID Seal Tags in Collaboration with Health Care Logistics for Hospital Pharmacy Kit Safety Chicago, IL – October 08, 2014 – Kit Check™ (http://kitcheck.com), the leader in hospital pharmacy kit processing and medication tracking software,...
Recent Comments